Perfecting the Pathway

Procedural excellence is setting higher standards with faster procedures, shorter hospital stays, and less rehospitalization.

Procedural excellence is setting higher standards with faster procedures,
shorter hospital stays, and less rehospitalization.

Procedural success helps to reduce the patient footprint

Click each tab for more related information

Shorter procedure times with SAPIEN 3 TAVI

With fewer complications, you achieve faster procedures, freeing you to help more patients.

Aortic Valve Replacement (AVR) procedure time

SAPIEN 3 TAVI could allow treatment of 2 to 3 additional patients per day in a single room with a single team.

View next topic

With less procedural complications, which predict mortality and hospitalization times, more resources are freed up to treat more patients

View next topic

Potentially lowering patient exposure to the healthcare system

Early Discharge1

80.1% Next day

80.1%

Next day

89% Procedure + 48 hours

89%

Procedure + 48 hours

View next topic

Choosing SAPIEN 3 TAVI can help your patients stay out of the hospital

*As defined in the PARTNER 3 trial: valve related, procedure related, cardiac related rehospitalization.

View next topic

The Edwards Benchmark program

The optimised pathway is designed to improve access to high quality of care, improving patient outcomes and enabling early discharge.1,6

1%

30-day
Mortality2

1%

30-day
Stroke2

1%

30-day
Major Vascular
Complications1

6%

30-day
Permanent
Pacemaker3

4%

30-day Cardiac
Readmissions2

80%

Next Day
Discharge
Home3

Resource Center

View All Resources
SAPIEN 3 Ultra Higher Standard Brochure
Higher Standard One Page Sheet

References:  

1. Wood DA, Lauck SB, Cairns JA, et al. The Vancouver 3M (multidisciplinary, multimodality, but minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve relacement centers: the 3M TAVI study. JACC Cardiovasc Interv. 2019;12(5):459-469.
2. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695-1705.
3. Data on file, analysis of 2018 Medicare SAF files.
4. Data on file.
5. Nazif T, Daniels D, McCabe J, et al. Real-world experience with the SAPIEN 3 Ultra TAVI: A propensity matched analysis from the United States. Presented virtually at TVT Connect 2020.
6. Barbanti M, van Mourik MS, Spence MS et al. Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: The multicentre European FAST-TAVI trial. EuroIntervention. 2019;15:147–54.